Endonasal endoscopic treatment of recurrent dacryocystitis

Cell Biochem Biophys. 2013;67(3):1441-4. doi: 10.1007/s12013-013-9684-7.

Abstract

This report assessed clinical conditions leading to recurrent dacryocystitis and success rates of its treatment by endonasal endoscopic dacryocystorhinostomy. Forty-eight patients with recurrent dacryocystitis underwent endonasal endoscopic surgery and were followed up for at least 6 months. High bone windows, small bone window openings, small lacrimal sac stomas, scar tissues, and organic diseases of the nasal cavity led to fistula closure. Out of 48 patients, 45 (93.8%) patients were cured by endonasal endoscopic surgery. Endonasal endoscopic dacryocystorhinostomy is beneficial for recurrent dacryocystitis.

MeSH terms

  • Adolescent
  • Adult
  • Dacryocystitis / surgery*
  • Dacryocystorhinostomy
  • Endoscopy
  • Ethiodized Oil / chemistry
  • Female
  • Humans
  • Lacrimal Apparatus / diagnostic imaging
  • Male
  • Middle Aged
  • Recurrence
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Young Adult

Substances

  • Ethiodized Oil